How is Idexx Laboratories (IDXX) doing?

Idexx Laboratories is a company in the medical, diagnostics & research industry, based in Westbrook, ME, worth $40.9B. Here is how its shares and business compare with the rest of the market, and where it shows up on our dashboards.

Updated Oct 9, 2026

P3 score

Middling

Idexx Laboratories shares are down 18% over the past year, 29 points behind the S&P 500. Its type is Coiled Spring. Among large US stocks and funds it ranks in the 17th percentile on market beat, the 70th on staying power and the 87th on business growth. It appears on 7 of our dashboards.

$518.00−18% in a yearWorth $40.9B

Compare with ZTS · ELAN

Financials, earnings and news on Stox ›

Past year

The past year

Price against the S&P 500, each set to $100 a year ago. Score is its weekly rank against the market. Select a tile for that score month by month.

IDXX against the S&P 500, past year

$100 a year ago. Idexx Laboratories −18%, the S&P 500 +16%.

IDXXS&P 500

What kind of stock is it?

Its type on Stox Atlas, from its four scores: beating or lagging the market, a steady or erratic rank, a growing or slowing business, and whether buyers or sellers lead.

Coiled Spring

LaggingSteadyGrowingBought

Behind the market but holding its rank, with a growing business and buyers stepping in.

NovDecJanFebMarAprMayJunJulAugSepNow

Coiled Spring this month; Turning Up before that.

Also Coiled Spring (60 in all): INSP · ALNY · BSX · PODD · AFRM · RRC

EmbracedToppingAccumulatingRejectedStable rankBellwetherDistribution TopCoiled SpringWallflowerHolding rankFaith TradeRolling OverBottom FishedSleepy StapleUnsteady rankHot HandChurning WinnerTurning UpShow-Me GrowerBouncy rankSpeculative PopExhausted RallyFalling KnifeBroken Year

How is it doing against its group?

Its group is Health care, 86 large US stocks and funds whose prices tend to move together. Tools, biotech and large-cap pharma — defensive growth.

IDXX, past year−18%71 of 86 in the group

Rest of the group+21%equal-weighted

S&P 500+16%past year

Idexx Laboratories is −18% over the past year, against +21% for the rest of the group and +16% for the S&P 500. It ranks 71st of 86 in Health care.

IDXXRest of the group

Best in the groupRVMD Revolution Medicines+297%ILMN Illumina+184%NTRA Natera+133%

Worst in the groupPODD Insulet−57%BSX Boston Scientific−56%RARE Ultragenyx−50%

Its closest rivalsZTS Zoetis−48%ELAN Elanco+13%

Health care on Stox ›

How much does it move?

Its typical daily move, against its own past year, the market and other large stocks. Swings describe risk, not direction.

About usual Idexx Laboratories typically moves 2.5% in a day, about usual for it, and it swings less than 57% of large US stocks.

Typical day2.5%about $12.81 a share

Its usual2.9%about usual, 0.8× its year’s average

Against the S&P 5002.6×the index’s typical day is 1.1%

Unusual day±4.9%twice its typical day

Deepest fall, past year−34%now 32% below its high

In the S&P’s down weeks115%of the index’s fall, three years; beta 1.0

Typical daily move (ATR)Its year’s average 2.94%

IDXX on our dashboards

Every question where Idexx Laboratories appears, in the order of the home page, with its reading and place in that table. Select a question to open it with IDXX highlighted. Select a column to sort.

Question	Reading	Place	Details
How much do stocks move on earnings? Earnings	89Big mover	44 of 60	Reports 2026-11-02 · Typical move 9.1% · Largest 20%
Who beats estimates every quarter? Earnings	8812 in a row	60 of 60	Run 12 · EPS beats 12 of 12 · Sales beats 8 of 12
Which stocks keep losing? Leading stocks	9834 of 52 wks	12 of 60	vs S&P, 1Y −33 pts
Which companies earn the most on their capital? Business quality	93Excellent	29 of 60	Return on capital 44% · Gross margin 62% · Cash margin 24%
Which stocks are cheap against their own history? Value	99Cheap	29 of 60	P/E now 36.7x · 10-yr median 54.0x · Earnings, 1Y +18%
Which stocks fell even though the business grew? Value	–	22 of 38	Price, 1Y −18% · Sales, 1Y +13% · EPS, 1Y +18%
Which stocks are priced for perfection? Value	88Rich	46 of 60	Forward P/E 31× · EV / sales 9.6× · Expected EPS growth +14%

Go deeper on Stox

IDXX’s full profile: financial statements, earnings and analysts’ estimates, valuation against its sector, recent news with a summary, and its scores in detail.

Open IDXX on Stox ›All 16 types on Atlas ›Its group on Stox ›

How to read this page

How it’s measured. Scores from Stox rank the stock against about 1,200 S&P 500, Nasdaq-100 and Russell 1000 stocks and popular funds, where 100 is best; market beat and staying power use prices, business growth uses revenue, margins and cash flow. Readings on other dashboards come from this site’s pages.

Sources. Daily prices and company financial statements from Financial Modeling Prep; scores and co-movement groups from Stox.

Scores are percentiles: 80 means the stock ranks above 80% of the others on that measure. They describe the recent past and are not advice or a forecast.

Its type follows Stox Atlas: each of the four scores is split at 50. “Steady” means its rank has held, high or low, so it says nothing on its own about direction.

Its group is the cluster of large US stocks whose prices have moved together over five years, with the market’s own moves taken out. The typical daily move is the average true range over 14 days, a measure of how far the price travels in a day including overnight gaps.

For financial statements, earnings and news, see IDXX’s full profile on Stox.

This page is information, not investment advice. About our data and methods ›

Full profile on Stox ›Health care stocks ›ZTS · Zoetis ›ELAN · Elanco ›